PRINCIPAL FINANCIAL GROUP INC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1126328
DES MOINES, IA
Position in SRPT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$9,175,571
-$1,912,280 QoQ
Shares Held
510,605
+0.2% QoQ
Ownership
0.483%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. SRPT ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,175,571 | 510,605 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $11,087,851 | 509,552 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $10,701,357 | 497,275 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $9,019,650 | 468,067 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $3,828,450 | 223,886 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $15,620,965 | 244,766 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $34,298,593 | 282,084 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $33,350,250 | 267,037 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $57,355,738 | 363,011 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $5,920,723 | 45,734 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $4,777,045 | 49,539 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $2,665,627 | 21,990 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $2,427,251 | 21,195 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $2,898,151 | 21,027 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,032,948 | 23,406 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $2,201,292 | 19,914 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $1,603,768 | 21,395 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,363,505 | 17,454 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $1,677,270 | 18,626 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,200,931 | 23,799 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,082,032 | 26,782 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $2,000,757 | 26,845 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $4,319,704 | 25,337 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $3,528,724 | 25,128 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $4,367,821 | 27,241 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,901,424 | 19,438 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||